Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott ...

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global ...

Fintel reports that on October 17, 2025, Barclays maintained coverage of Abbott Laboratories (NYSE:ABT) with a Overweight ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning.

Abbott Laboratories (ABT) reports robust earnings with significant contributions from medical devices and new product ...

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical ...

Abbott Laboratories (NYSE:ABT) develops, manufactures, and sells healthcare products, including pharmaceuticals, diagnostics, ...

Abbott (NYSE: ABT) shares dipped before hours today on third-quarter results that fell short of the consensus Wall Street ...

Abbott Laboratories (ABT) stock drops as the company's Q3 2025 results miss revenue estimates as diagnostics unit contracts ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, ...

Abbott Laboratories (ABT) stock is in focus as Walmart (WMT) is set to become the first physical retailer to sell its Lingo ...

Abbott Laboratories (NYSE:ABT) is one of the top low volatility healthcare stocks to buy now. Analyst Mike Kratky from Leerink Partners reiterated a Hold rating on Abbott Laboratories (NYSE:ABT) on ...